VILLA GUARDIA (COMO), Italy, June 16, 2011 (GLOBE NEWSWIRE) -- Gentium S.p.A. (Nasdaq:GENT) announced the appointment of Gen Ilac A.C. as exclusive distributor of Defibrotide in Turkey. Under the terms of the agreement, which is valid for 10 years, Gen Ilac will be responsible for managing named patient requests, achieving registration, marketing authorization and reimbursement within Turkey. Following regulatory approval, if any, Gen Ilac will be responsible for sales, marketing and local medical affairs activity as it relates to Defibrotide.
